Trial Profile
Proteinuria in patients with bevacizumab (Avastin): Identification of potential protein biomarker candidates for monitoring treatment side-effects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Jul 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications CNS cancer
- Focus Adverse reactions; Pharmacodynamics
- 02 Jun 2011 New trial record